Enliven Therapeutics (ELVN) Soars to 5-Year High as Analysts ‘Upbeat’

Enliven Therapeutics Inc. (NASDAQ:ELVN) is one of the 10 Stocks Investors Are Buying Now. Enliven Therapeutics soared to a new five-year high on Wednesday, as investors took heart from two analysts’ optimistic coverage for the stock, with one raising its price target by 9.7 percent. In intra-day trading, the stock climbed to a record high of $36.65 before paring gains to finish the session just up by 14.06 percent at $35.53 apiece. Bicycle Therapeutics (BCYC) Appoints Travis Thompson as CFO Following Le ...